Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GNMSF) Net Income (2024 - 2025)

Historic Net Income for Genmab A (GNMSF) over the last 2 years, with Q4 2025 value amounting to -$1.1 billion.

  • Genmab A's Net Income fell 32224.35% to -$1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1204.0, marking a year-over-year decrease of 9999.99%. This contributed to the annual value of -$241.0 million for FY2025, which is 12127.09% down from last year.
  • According to the latest figures from Q4 2025, Genmab A's Net Income is -$1.1 billion, which was down 32224.35% from $482.0 million recorded in Q3 2025.
  • Over the past 5 years, Genmab A's Net Income peaked at $517.0 million during Q4 2024, and registered a low of -$1.1 billion during Q4 2025.